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~U~ transmyoc~rd~l  mv;~sct~!nzat~on (TMR) has ~n repoI1eO tO 
lmpt~ye dm~ out~ in ~ WI!fl irg~actoty anglnal '.'4 ha am I~| CaP4P4~ t~~3 
10{ PTC, A m CABG We ~ a nonsurg~a! t ra~lhete~ lecbfl~q~, PTMR 
in 8 su~ch pls (mean age 63 ± t l  years). All 8 had Clasa II! (2 pts) o~ Class 
tv (6 p~) angina. Ni had ~ 0l ~n~~l~ i~m=a and bad an eiec, 
tton ~ »~5%, PTMR was ~ ~  u.~mg qlP Fcllpse HÒl~|tml lase~ 
|d~(eopt~ syslem. ~ ~Is  wem ~ in the LV, ~ succe551~|~y 
in all p~ I~t s~nnt~aneou$ flt~rO~"Of)y and I'~.~~ll-pta~ t m ~ l  
cardmg~ tTIEE) A total ot 13.5 ± 4 channels (5 mm dee~) wem tased 
en the segment ol tt~e LV correspoo~ng to the target co~onaqf aneqt Total 
pmcedum ltme was 50 ± 8 m~s, w~~ total ffu~o t~me o! 13 ~: 7 rums. No 
~lto~s  Were encou~teredL NI pls ~ m~pro~ement m angmal 
sym~oms and all wem d~charged fr0m the hosp~l w~lh:n 48 hours after 
lasmg. Fo~ow-up at 2 months ~ no deaths and all had susta~~=d cBn- 
i n ~  (Ctass I In $ and Class Il m 3). On fO~tOw-up stress test 7 of 
8 ptS wem ab~e to exermse for at least 6 mtns, com~tebng ~ stage o~ Ga~e 
pro~oco~ tt~thout angina. Tha~~um images sbowecl sKJn~ficant ~ ~ n !  ~n 
3 ptS and no ct~--nge =n 4. S=x months tolk~w-up stures ~|1 be presenteO. 
Cot~Y~~o~ PTMR aRoears to be a feas=b~e affematn~e to TMR m pts wtm 
mfracto~ a ~  not amenab~ to am/form of revascu~anzat~on. 
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~ß-~-~ Ang.Z~raphic Follow-up of Cutt|ng Balloon vs 
ConvenUonal BaUoon Angioplasty. Results of the 
CUBA Study  
c Mans. A_ Bethencourt. M Gomez-Reoo P Bordes. J Auge. 
R Me~gams, J Heman~ez. J Zueco. J Dom~nguez, J C-~co~ea Hosp#a,' 
Chn~co Sah Cado~ Madnd. Spam 
The CUBA Stud,/is a random~zed and mutt)center study companng Cutt)ng 
Baltoon (CB) vs corwenbonal ang~oplasty (Bal) ~n sm~fe de novo les=ons We 
report hefe the immediate results as weil as the ar~ograph¢c follow-u~ A 
total ol 306 p~bents wem final~y included (153 wem randomized to Bal and 
153 to C-B). Clin~cal (age 59 vs ,57: fem~fe genfer 20 vs 19%; Dfdbet'es 2
13%) were simdar. Base~ine les~on charactenst~cs wem also sin'ùlar (types 
B1 + B2 63% in Bal vs 67% in CB). Protoco! success was obtained in 136 
(89%) in the Bal group (18 required Stent~) vs 139 (91%) in C-B 12 pabents 
required Stents ÷ 1% crossed over to baltoon PTCA. Minimal lumen diameter 
(MLD) increased from 05 ± 0.5 to 2 ± 0.4 mm (gmn = 15 ± 0,4) in the Bal 
group vs 0.6 ± 0.6 vs 2 = 0.4 (garn = t.46), P = NS. rh~re wem few malor 
complcaticms (3% in Bat vs 2%, P = NS) w~th no deaths in either group. F-U 
angiography and ana[ys¢s was performed in a ~er protocol princ~ple and was 
pedormed in 96% ol pattents. Restenosis was 42°.0 in Bal vs 30% in CB (RR 
= 1.66. 95% CI = 1--2.8; P = 0.047). MLD at FU was 1.5 ~ 07 in ~a! vs 1.66 
± 0.8: Loss 0.52 ~- 0.7 vs 0.37 -~ 0.8 P = 0.09). 
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Conclusion: CB provides similar acute clinical and angiographic results 
as compared to Bal. A moderate benefit in restenosis with CB is obs~«ed 
due to a smaller laie Ioss. 
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Percutanoou0 In-$1tu ~nMy Aftery Bypass 
(PICAB): A Novel I~-o .ard la l  Retms¢uladzation 
Technlque 
S.N. Oestefle, A,C, Yeung, M Hayase, R,C, Robbins, P Fi~g~r~~, p Y~k, 
R Kemoff, M, "ruinös, R, Vim~nt, J, Makow~t C~~ ~/henzaff/on & 
Coronan/tnter~~nfion ~l~atone=~ Cam~wasc~t~r ,~~ß~ne= $!«~n/  
Un«~m@ Med~l C~ter, Stan~'d, C~10m~, USA 
The h~rnan ¢ofonaW ve~ Or¢gl~tion h~a fi~vo~able anatomy and pt~~.  
ogy that pem~ts it to be ~ as an m-s~g ¢orona~/ane~y bypass galt, We 
~n a por~ne maclel, Working mmu~h the Comna~y $inus (CS), a~~no,ve~ous 
conne¢Imn~ am ma(~ wflh ,1 novel cathetor system that caa ipm¢isely Iocate 
the target artefiat ~~lment Both ~ravascuta~ l t r~ and fluOm~O~ 
am used to betp pos~t~ and one~ the ~athet~r ~ ,  The, cathetef eot~ 
SiSIS O! an extendat~e heere thal IS useß Io pur~~re the ~rtery (CA), makfr~ 
the mma! venous • arteflal c'o~nectzon A gu~ewlm (GW) is lhen ~Nered 
horn the c0ronary rein (V) to CA, prov'~ing a "mit" ovet" wmch a sertes at 
othef de~::es can be äelivered, A (:flanrmlmg dev¢ce is then passed over the 
w,re ~tmg a ltsluta, and allowm9 flow between the two vessels, Foflowmg 
c~eat~on of the pto~rma! and d~~la! V to CA co~nect~~ns, the vtmous segment 
~s ,sotated by means of spe¢ially (:JeS~oneO occtuswe ~ s  tsolatton at 
segments of the venous anatomy dlcl not eventuam in untowar0 phys~0tog~c 
cot~seqt~~. The Cr~~hon of mul t~ in-srlu bypasses is fe~sible ulilizmg 
th~s tectmKlue. PICAB (:an be accompl;shed m an antmal mo¢lel and hok~ 
promLs~ ,*r.r human ap~~cat~on Hemodynam~, ang~0grap~~: and histo|O~ 
dar3 from por~ne PICAB studies ~11 be pmsented. 
Intravas©ular Ultrasound Insights Into the 
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Atherosclerosis 
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4:00 • Impaired Va~-ular Ot~lensibil ity Pdor to Intimal 
Proliferation in Traw=plant Va~--ulopathy 
Y. Hort¢ta. JD. Perfroth, M Hayase, NP. Bnffa. TS. Ikonen, J.F. Gummert, 
Y Kobayasht. C Bartow. B. Hausen. P J  Ftlzgerald, R.C Robbins. 
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Trans~~an! vasculopathy remaJns a major hmdabon to tang term survlval tn 
heart transptantab0n TO assess the t]me course at transplant vascufopamy m 
a pnmate model at cflromc aflograft relec~on , four monkeys wem studied us- 
mg senat =ntrava~cular ultrasound (IVUS) w~th s=multaneous bloo~ pressure 
(BP) recoming at baserme, dm/24 and day 52 after aorlic ~ransplantatmn, 
32 cross-sect~ns (isograft: 12, alfograft 20) wem mat¢fled, and vesse| d|- 
mensmns [lumen area (LA), total vessel area (VA), and mttmal area (lA = 
VA LA)] wem measured at end-cliastole and end-systole, A stiffness index 
B, co¢~fderecl to be lndependent of BP. was ¢alculated with the fo|lowmg 
to~Tnufa;/~ =[in (systolm BPfdiasto#ic BP)V(AL/Vend-diasto(rc LA). 
ResuttS: In the aIfograffs, a progmsstve increase in # was observed at 
both day 24 and day 52 (line chart) while lA mgnificantly incmased o~ly at 
day 62 (bar chart), In contrast, the isografts showed no significant change m 
B or lA. 
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Conc/usion: Impaired vesodar distenstbility of the aflograMs occurred 
pnor to onset of significant mtimal hyperplasia, and detenoratecl through0ut 
the study period. These findings suggest that early abnormality in vaS¢u~ar 
distensibility detected I~, IVUS might identify patients at risk for subsequent 
progression of transplant vascufopathy. 
